High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization
One-year results from the SCORE randomized trial
Eberhard Grube, MD, FACC*,*,
Alexandra Lansky, MD, FACC ,
Karl Eugen Hauptmann, MD ,
Carlo Di Mario, MD, FACC ,
Germano Di Sciascio, MD, FACC||,
Antonio Colombo, MD, FACC¶,
Sigmund Silber, MD, FACC#,
Juergen Stumpf, MD**,
Nicolaus Reifart, MD, FACC ,
Jean Fajadet, MD ,
Antonio Marzocchi, MD ,
Joachim Schofer, MD||||,
Pierre Dumas, MD¶¶,
Rainer Hoffmann, MD##,
Giulio Guagliumi, MD***,
Mark Pitney, MD  and
Mary E. Russell, MD, FACC 
* Herzzentrum, Siegburg, Germany
Cardiovascular Research Foundation, New York, New York
Krandkenhaus Barmherzige Brueder, Trier, Germany
San Raffaele Hospital, Milan, Italy
|| University Campus Biomedico of Rome, Rome, Italy
¶ Columbus Hospital, Milan, Italy
# Cardiology Clinic, Munich, Germany
** Praxisklinik Kardiologie Angiologie Radiologie, Dresden, Germany
 Main-Taunus Heart Institute, Bad Soden, Germany
 Clinique Pasteur, Toulouse, France
 Universita degli Studi Policlinico S. Orsola Istituto di Cardiologia, Bologna, Italy
|||| Center for Cardiology and Vascular Intervention, Hamburg, Germany
¶¶ Clinique du boise de Verriers, Antony, France
## Universitatsklinikum der RWTH Aachen, Aachen, Germany
*** Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy
  Prince of Wales Hospital, New South Wales, Australia
  Boston Scientific Corporation, Natick, Massachusetts

View larger version (38K):
[in a new window]
|
Figure 1 Photograph of the QuaDDS stent with five polymer sleeves.
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Freedom from (A) major adverse cardiac event (MACE) and (B) target lesion revascularization (TLR) post-procedure.
|
|
|